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Objective: In isolated myocytes cardioplegia-induced cell swelling can be
prevented by lowering the KCl product by replacing Cl– with an imper-
meant ion. This study tested the hypothesis that Cl– substitution in St.
Thomas’ Hospital cardioplegic solution would result in superior myocar-
dial protection in the intact, blood-perfused heart. Methods: Using a
parabiotic, isolated rabbit heart Langendorff model, hearts were exposed to
1 hour of hypothermic (10° to 12o C), global ischemia followed by 30
minutes of reperfusion. Isosmotic cardioplegia was administered as a single
50 ml bolus of either standard St. Thomas’ Hospital solution ([K1]o 3
[Cl–]o 5 2566.4 (mmol/L)
2) or low Cl– St. Thomas’ Hospital solution
([K1]o 3 [Cl
–]o 5 700 (mmol/L)
2). Chloride was replaced by a large,
impermeant ion, methanesulfonate. Postreperfusion systolic function and
atrioventricular conduction times were measured before ischemia and after
reperfusion. Results: Hearts receiving low Cl– St. Thomas’ Hospital cardio-
plegia demonstrated significantly better postischemic functional recovery
(74% 6 3%) compared with those treated with standard high Cl– St.
Thomas’ Hospital solution (55% 6 4%, p 5 0.003). In addition, atrioven-
tricular conduction times remained normal in the low Cl– group but were
significantly prolonged in the St. Thomas’ Hospital group. Conclusions:
Lowering the KCl product of St. Thomas’ Hospital solution makes it
isotonic with plasma and prevents cellular edema. This ameliorates the
detrimental functional and electrophysiologic sequelae of hypothermic,
hyperkalemic cardioplegia. (J Thorac Cardiovasc Surg 1998;115:1196-202)
Previous attempts to prevent myocardial edemahave focused on the osmolarity of the cardiople-
gic solutions and the use of membrane stabilizing
agents.1-4 However, a solution may be isosmotic with
plasma and still induce cell swelling if it is hypotonic.
Although osmolarity is an intrinsic property of the
solution, tonicity depends on the properties of both
the solution and the cell membrane, and membrane
properties are highly sensitive to temperature.5 Re-
cent studies on isolated rabbit and human myocytes
suggest that edema may be a direct consequence of
the tonicity of isosmotic cardioplegic solutions.6, 7
Lowering the KCl product by partially replacing
[Cl–]o with a large, impermeant ion made St.
Thomas’ Hospital solution isotonic and prevented
cell swelling during the period of exposure.6 How-
ever, extrapolation of data from single myocytes to
the intact heart must be done cautiously. The single
cell model fails to incorporate the myriad interac-
tions between myocytes and neural, vascular, and
interstitial elements, and the complex geometry of
the intact heart.6, 7 Therefore this study was de-
signed to test the hypothesis that the prevention of
cellular swelling by changing the tonicity of the
cardioplegic solution would ameliorate the detri-
mental contractile and electrophysiologic sequelae
of hypothermic, hyperkalemic cardioplegia in the
more clinically relevant intact heart.
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Methods
Adult New Zealand White rabbits of either sex, weigh-
ing 2.8 to 3.1 kg, were used in this study. All animals
received humane care in American Association for the
Accreditation of Laboratory Animal Care–approved,
United States Department of Agriculture–registered fa-
cilities in compliance with the “Principles of Laboratory
Animal Care” formulated by the National Society for
Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Labo-
ratory Animal Resources and published by the National
Institutes of Health (NIH Publication No. 86-23, revised
1985.) Experiments were designed to compare the effect
of standard and low Cl– St. Thomas’ Hospital cardioplegic
solution on postischemic function of hearts mounted and
perfused on a parabiotic Langendorff apparatus.
Experimental preparation
Preparation of the support animal. The support animal
was anesthetized by intramuscular administration of
acepromazine maleate (INN: acepromazine) (1 mg/kg)
and xylazine (17.5 mg/kg) followed by ketamine (62.5
mg/kg). A tracheostomy was performed, and mechanical
ventilation was initiated (model 683, Harvard Apparatus,
Dover, Mass.). Ventilator settings were adjusted to main-
tain arterial pH between 7.35 and 7.5, carbon dioxide
tension (PCO2) between 35 and 45 mm Hg, and oxygen
tension (PO2) more than 200 mm Hg.
Heparin (2500 U) was given through an ear vein. The
right femoral artery was cannulated, the cannula con-
nected to a pressure transducer (model P231D, Gould
Inc., Cleveland, Ohio), and blood pressure was continu-
ously displayed. Systolic blood pressure was maintained
greater than 80 mm Hg by transfusion of either blood
collected from the donor animal or electrolyte solution
(Plasma-Lyte, Baxter Healthcare Corp., Deerfield, Ill.),
and serial hematocrits were measured.
The left internal jugular vein and carotid artery were
cannulated to provide extracorporeal circulation, and
arterial blood was delivered to perfuse a modified Lange-
ndorff apparatus as described previously.8 Column efflu-
ent was returned to the support animal.
Preparation of the donor animal and isolated heart. The
donor animal was also prepared as described above. A
rapid cardiectomy was accomplished through a median
sternotomy, and blood for transfusion was collected from
the thoracic cavity. The aorta was rapidly cannulated, the
heart suspended from a modified Langendorff apparatus,
and blood perfusion begun.
To monitor contractile function, a fluid-filled latex
balloon was placed into the left ventricle and secured with
a purse-string suture in the mitral valve anulus. The
balloon was connected by way of polyethylene tubing to a
pressure transducer (model P231D, Gould, Cleveland,
Ohio). The zero pressure reference was set at the level of
the aortic valve.
Two needle electrodes were secured in the right atrial
appendage and connected to a pacemaker (model 5320,
Medtronic, Inc., Minneapolis, Minn.). The heart was
paced at a constant rate throughout the study. Two
additional electrodes were placed on the left ventricular
epicardium to monitor a bipolar electrogram. The elec-
trodes were connected to a preamplifier and amplifier
(model 11-G5407-58 and 13-4615-58, Gould Inc.) and
band pass filtered between 0.05 and 1000 Hz. The pres-
sure and electrogram waveforms were displayed continu-
ously and digitized at 1000 Hz with a WINDAQ/200
system (DATAQ Instruments, Akron, Ohio). Coronary
flow was measured by an in-line flow probe and continu-
ously monitored with a flowmeter (model T206, Transonic
Systems, Inc., Ithaca, N.Y.).
The heart was enclosed in a water-jacketed beaker, and
myocardial temperature was monitored with a probe
placed in the right ventricle (model BAT 8, Bailey Instru-
ments, Saddle Brook, N.J.). Hearts were warmed and
cooled by switching flow between a 37° C water bath
(model D1, Haake Co., Berlin, Germany) and a 10° C
water bath (model 9010, Fisher Scientific, Pittsburgh, Pa.)
connected in parallel to the water-jacketed beaker. Blood
perfusate was maintained at 37° C by a separate water
bath (model D1, Haake Co., Berlin, Germany). At hourly
intervals, heparin (500 U) was administered to the support
animal.
Experimental protocol. After instrumentation, hearts
were given 30 minutes to equilibrate, and baseline data
were acquired. Hearts that did not generate a systolic
pressure exceeding 80 mm Hg at an end-diastolic pressure
(EDP) of 10 mm Hg were excluded from the study.
Intracavitary left ventricular pressure waveforms and left
ventricular bipolar electrograms were recorded at seven
fixed left-ventricular end-diastolic pressures (LVEDP) (0,
2.5, 5, 10, 15, 20, and 25 mm Hg) attained by adjusting
balloon volume. Then balloon volume was reduced to
produce a 5 mm Hg LVEDP.
Hearts were randomized to undergo a single 50 ml
infusion of one of two cold cardioplegic solutions (10° C)
at the onset of 60 minutes of global ischemia (10° to
12° C). Either standard St. Thomas’ Hospital solution
([K1]o 3 [Cl
–]o 5 2566.4 [mmol/L]
2, Plegisol, Abbott
Laboratories, North Chicago, Ill.), or a modified, low Cl–
St. Thomas’ Hospital solution was administered.6
Low Cl– St. Thomas’ Hospital solution ([Cl–]o 5 43.75
mmol/L) was made by substituting an equimolar amount
of Na-methanesulfonate for all NaCl and K-methanesul-
fonate for part of the KCl in St. Thomas’ Hospital solution
so that the product [K1]o 3 [Cl
–]o was 700 (mmol/L)
2.
This low Cl– cardioplegic solution is isotonic and did not
affect the volume of isolated myocytes.6 Methanesulfonate
was chosen as the substitute for Cl– because it is a large
impermeant anion that does not chelate Ca21. Further-
more, its pKa of approximately 1.2 is sufficiently low that
negligible amounts of the permeant protonated species
are present at physiologic pH.6 The osmolarities of the
standard and low Cl– solutions were not significantly
different (243 6 5 and 237 6 6 mOsm, respectively).
To examine whether methanesulfonate itself had a
cardioprotective effect, another large impermeant anion,
aspartate, was used to lower the [K1][Cl–] product. As-
partate also has a low pKa. In this group (n 5 6),
equimolar amounts of Na-aspartate was substituted for
all the NaCl and K-aspartate for some of the KCl in
St. Thomas’ Hospital solution. This also lowered the
[K1][Cl–] product to 700 (mmol/L)2.
After 1 hour of global ischemia, hearts were rewarmed
and reperfused for 30 minutes. Intracavitary left ventric-
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ular pressure waveforms and electrograms were recorded
every 5 minutes during the reperfusion period at a fixed
balloon volume corresponding to a preischemic LVEDP
of 5 mm Hg. After 30 minutes of reperfusion, data were
acquired over the identical range of balloon volumes
examined before ischemia. At the conclusion of the study,
a sample of the left ventricle was excised, blotted,
weighed, and then dried until a constant dry weight was
reached. The extent of myocardial edema was determined
by calculating percent tissue (%H2O):%H2O 5 (Wet
weight – Dry weight)/Wet weight.
Data analysis. Digitized pressure waveforms were an-
alyzed, as described previously, using software developed
in our laboratory.9
End-systolic pressure. End-systolic pressure (ESP) was
calculated for each of the seven preischemic and seven
postreperfusion balloon volumes. The ESP-volume rela-
tionship (ESPVR) was fitted with a least-squares linear
regression:
ESP 5 Emax 3 V 1 k
where Emax was the slope of the ESPVR, V was the
balloon volume, and k was the y-axis intercept of the
ESPVR.
EDP. EDP was calculated for each balloon volume and
the EDPVR was fitted with a least-squares linear regres-
sion:
EDP 5 m~V – Vo!
where m was the slope of the EDPVR and Vo was the
balloon volume at which EDP is zero or the x-axis
intercept. A linear representation of the EDPVR has
been shown to be appropriate over the limited range of
volumes examined in this model.10 The mean linear
repression coefficients for the EDPVR were 0.98 6 0.01,
and 0.99 6 0.00 for the standard and low Cl– St. Thomas’
Hospital solution groups, respectively. The slope of the
relationship was used as an estimate of diastolic compli-
ance.
Developed pressure. Developed pressure in the left ven-
tricle (DP) was defined as the difference between ESP and
EDP, and 10 consecutive beats were averaged for each
balloon volume. The pressure-volume relationship was
fitted using the following linear regression:
DP 5 ESP – EDP 5 ~Emax 3 V 1 k) – m(V – Vo)
Recovery of DP. The recovery of DP, expressed as a
percentage, was calculated as the ratio of the postreper-
fusion DP to the preischemic DP at the same balloon
volume. The average percent recovery of DP (%DP) was
determined from the following definite integral, approxi-
mated using the trapezoidal rule:8






where Vb was the largest matching postreperfusion bal-
loon volume and Va was the smallest matching postreper-
fusion balloon volume.
Statistical analysis. Results are expressed as the
mean 6 standard error of the mean. A one-way repeated
measures analysis of variance was used for comparisons
that involved sequential, time-based measurements.
When appropriate, the Kruskal-Wallis analysis of variance
on ranks was used as a nonparametric alternative. Indi-
vidual comparisons between groups were made using a
Tukey post test. A t test, or paired t test when appropriate,
was used for comparisons between two sets. A x2 analysis
of contingency tables was used to compare mutually
exclusive, categoric data where appropriate.
Results
There were no significant differences in pH, PO2,
PCO2, serum sodium, potassium, calcium, or hemat-
ocrit in the support animal between baseline data
acquisition and after 30 minutes of reperfusion. The
mean hematocrit was 31 6 1 at baseline versus 30 6
2 after reperfusion (p 5 0.53). There were no
significant differences in times to electrical and
mechanical arrest between low Cl– St. Thomas’
Hospital (28.2 6 2.8 seconds and 27.6 6 2.9 seconds,
respectively) and standard St. Thomas’ Hospital
solutions (31.4 6 3.2 seconds and 27.1 6 1.2 sec-
onds, respectively).
Postischemic diastolic compliance. Postreperfu-
sion changes in diastolic compliance were quantified
by determining the slope of the LVEDP-V (Table
I). Both groups demonstrated significantly de-
creased compliance after reperfusion compared
with before ischemia. However, there was no differ-
ence between standard and low Cl– solutions.
Postischemic systolic function. Low Cl– St.
Thomas’ Hospital cardioplegia resulted in signifi-
cantly improved recovery compared with standard
St. Thomas’ Hospital cardioplegia as assessed by
%DP (Table I). The systolic dysfunction presented
early in the reperfusion period and remained con-
stant over the 30-minute reperfusion interval (Fig. 1).
Table I. Postreperfusion percent recovery of
developed pressure and slopes of the LVEDP-
diastolic volume relationship under preischemic
conditions and after reperfusion
%DP mb mr
Standard StT (n 5 8) 55.1 6 3.7 156.1 6 13.8 175.0 6 14.9†
Low Cl2 StT (n 5 8) 73.7 6 2.6* 180.9 6 24.5 203.4 6 22.6†
Values are expressed as mean 6 SEM. mb, Preischemic slope of the
LVEDP-V relationship; mr, postreperfusion slope of the LVEDP-V
relationship; St T, St. Thomas’ Hospital cardioplegia.
*Statistically different from Standard StT (p 5 0.003).
†Statistically different from respective mb (paired t test, p 5 0.044 and
0.028 for Standard and Low Cl2 StT, respectively).
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Coronary flow. Both groups exhibited a signifi-
cant increase in coronary flow immediately on
reperfusion (Fig. 2). Reperfusion hyperemia lasted
longer in the low Cl– St. Thomas’ Hospital group. At
5 minutes, the flow in the standard cardioplegia
group had returned to preischemic levels, whereas
coronary blood flow was still significantly elevated in
the low Cl– group.
Myocardial tissue water. Mean percent tissue
water for standard and low Cl– St. Thomas’ Hospital
cardioplegia was 78.0% 6 0.4% and 78.6% 6 0.2%,
respectively. There were no statistically significant
differences between the two groups.
Atrioventricular conduction times. The P-R in-
terval was significantly prolonged throughout the
reperfusion period compared with baseline in the
standard St. Thomas’ Hospital group (Fig. 3). In
contrast, no conduction delay was observed in the
low Cl– St. Thomas’ Hospital group.
Alternative anion. An alternative anion, aspar-
tate, was examined to investigate whether there was
any protective effect of methanesulfonate itself.
Both of the low Cl– solutions had identical [K1][Cl–]
products. The low Cl– St. Thomas’ Hospital solution
formulated with aspartate had an identical protec-
tive effect when compared with the methanesulfo-
nate group. There was a 69% 6 2% recovery of DP
in this group. This was significantly better than
standard St. Thomas’ Hospital solution (p , 0.05)
and not significantly different than the methanesul-
fonate group. Similar to the methanesulfonate
group, there also was no significant prolongation of
the P-R interval in the aspartate hearts, 119 6 5 msec
before versus 110 6 9 msec after ischemia (p 5 0.62).
Discussion
Under hypothermic conditions, the activity of the
transporters and pumps that normally regulate cell
volume are markedly depressed, which leaves only
passive fluxes of ions to modulate cell volume.6, 7, 11
Because of the high membrane permeabilities to K1
and Cl–, the KCl product inside the cell must equal
the KCl product outside the cell under these condi-
tions.5 This would predict that cell swelling would
occur with exposure to St. Thomas’ Hospital solu-
tion because St. Thomas’ Hospital solution has a
much greater KCl product (2566.4 [mmol/L]2) than
either blood plasma (350 to 550 [mmol/L]2) or
Fig. 1. Developed pressure (DP) under preischemic conditions (time 5 0 minutes) and effect of standard
and low Cl– St. Thomas’ Hospital solution on DP during the reperfusion period (time 5 60 to 90 minutes).
Values are expressed as mean 6 standard error of the mean. *Significant difference versus St. Thomas’
Hospital solution, with p values shown in parentheses.
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physiologic crystalloid (e.g., Tyrode’s solution, 700
[mmol/L]2). By lowering the KCl product of car-
dioplegic solution while maintaining osmolarity con-
stant by partially replacing [Cl–]o with a large,
impermeant ion, cell swelling was prevented in
isolated myocytes.6 This study was designed to ex-
amine whether lowering the KCl product would
improve myocardial protection in an intact, blood-
perfused heart.
Functional consequences of low Cl– hyperkalemic
cardioplegia. Lowering the KCl product signifi-
cantly improved postischemic recovery of DP, ame-
liorating myocardial stunning. This is consistent with
the fact that intracellular edema has been shown to
result in ultrastructural disturbances such as mito-
chondrial swelling and vacuolization of the sarco-
plasm.12 Moreover, derangements in intracellular
volume may adversely influence the regulation of
cellular metabolism, hormone, and transmitter re-
lease.12-14 Further studies will be needed to address
the specific mechanisms involved in this injury.
An alternate explanation for our results is that the
Cl– ion possesses some inherent toxicity. However,
this ubiquitous ion has not been shown in any
previous study to be toxic within its physiologic
range of concentrations. Another explanation for
our findings would be that methanesulfonate itself
possessed inherent cardioprotective effects. How-
ever, we obtained identical results with an alternate
impermeant anion, aspartate. These data strongly
suggest that it is the correction of the hypotonicity of
the cardioplegic solution that is critical, not the
specific impermeant anion used to achieve this
result.
Low Cl– St. Thomas’ Hospital solution did not
offer better preservation of LV diastolic compliance
(Table I). This is not surprising. In isolated myocyte
preparations, cell swelling returned to baseline
within 20 minutes of reperfusion.6 In this study,
percent tissue water in the standard St. Thomas’
Hospital group was not significantly different from
that of the low Cl– St. Thomas’ Hospital group after
30 minutes of reperfusion. Thus one would not have
expected a change in ventricular compliance at that
point.
Coronary blood flow. Myocardial edema has
been associated with decreased coronary perfu-
sion.15, 16 In the standard St. Thomas’ Hospital
Fig. 2. Coronary blood flow (CBF) under preischemic conditions (time 5 0 minutes) and effect of
standard and low Cl– St. Thomas’ Hospital solution on CBF during the reperfusion period (time 5 60 to
90 minutes). Values are expressed as mean 6 standard error of the mean. *p , 0.05 versus respective
preischemic level.
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group an initial reperfusion hyperemia dropped to
preischemic values almost immediately. In the low
Cl– cardioplegia group reperfusion flow remained
elevated for 5 minutes (Fig. 2). One explanation for
this is that myocardial, or perhaps vascular, edema
early in the reperfusion period blunted the hyper-
emic response in the standard St. Thomas’ Hospital
group compared with the low Cl– group. As edema
resolved over the reperfusion period, coronary flow
returned to normal levels. Alternatively, whole-cell
patch-clamp studies of isolated rabbit coronary ar-
tery smooth muscle cells have characterized a chlo-
ride current that contributes to coronary vasocon-
striction.17 It is possible that coronary smooth
muscle activation was transiently affected by the low
Cl– milieu.
Atrioventricular conduction. Our laboratory and
others have shown that cell swelling and edema are
associated with slowed ventricular conduction.9, 18
In this study, the conduction delay observed after
standard cardioplegia (Fig. 3) was not seen in the
low Cl– cardioplegia group. In previous work, we
have hypothesized that the conduction delays asso-
ciated with hyperkalemic solutions were due to an
increase in cell volume, which decreased the extra-
cellular space, resulting in a higher resistance to
current flow.18, 19 This hypothesis is supported by
our observations in isolated myocytes6 and by this
study. Because slowed conduction velocity plays a
central role in arrhythmogenesis,20, 21 the postoper-
ative arrhythmias common after cardiac procedures
may be prevented by reformulating standard car-
dioplegic solutions.
Advantages and disadvantages of the blood-per-
fused isolated heart Langendorff model. The ad-
vantages and drawbacks of this model have been
previously described.8 The more physiologic nature
of this model is a distinct advantage over nonpara-
biotic and crystalloid-perfused models. However,
although this model offers a closer approximation to
the clinical scenario, care should be taken in extrap-
olating results from in vitro studies to the clinical
setting.
Conclusion
These results demonstrate a clear correlation
between the prevention of cell swelling and the
amelioration of the detrimental contractile and elec-
trophysiologic sequelae of hypothermic, hyperkale-
mic cardioplegia. Blood-perfused isolated hearts
treated with low Cl–, St. Thomas’ Hospital car-
dioplegic solution displayed significantly improved
postischemic functional recovery and shorter atrio-
ventricular conduction times when compared with
standard high Cl– St. Thomas’ Hospital solution.
New strategies aimed at correcting the hypotonicity
Fig. 3. Effect of standard and low Cl– St. Thomas’ Hospital solution on atrioventricular conduction times
after reperfusion. Values are expressed as mean 6 standard error of the mean. LOW Cl–, Low Cl– St.
Thomas’ Hospital solution; STANDARD, Standard St. Thomas’ Hospital solution. *p , 0.05 versus
preischemic P-R interval.
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of cardioplegic solutions and preventing cell swell-
ing may improve myocardial protection with hy-
perkalemic cardioplegia.
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